CDH2 and neoplasm: Experimental and clinical studies have further demonstrated the gatekeeper role of epithelial-to-mesenchymal transition (EMT) in modulating tumor invasion and metastasis, where CDH2 and VIM have been underlined to be involved (Thiery et al., 2009; Zhang et al., 2023).